ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,766Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 780

$950K Total Retail Price of All Prescriptions

Rank: 77 out of 780

1,006 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,006 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 1,006 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 8,372 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,123 355 S3 1 1
AMLODIPINE BESYLATE 639 329 2 4
PRAVASTATIN SODIUM 518 239 3 9
RANITIDINE HCL 477 271 4 39
SIMVASTATIN 470 266 5 2
LOSARTAN POTASSIUM 469 282 6 18
TRAMADOL HCL 460 167 7 15
GABAPENTIN 442 120 8 13
OMEPRAZOLE 397 203 9 3
FUROSEMIDE 395 211 10 7
HYDROCHLOROTHIAZIDE 393 201 11 10
FOSINOPRIL SODIUM 387 235 10 12 112
METFORMIN HCL 341 147 13 8
NEXIUM 307 116 14 22
CYCLOBENZAPRINE HCL 283 118 R 15 42
LISINOPRIL 274 131 16 6
CARVEDILOL 265 142 17 14
METOPROLOL TARTRATE 261 159 18 19
POTASSIUM CHLORIDE 259 135 19 11
ATENOLOL 253 133 20 21
SPIRONOLACTONE 244 121 21 53
FELODIPINE ER 242 149 22 126
MELOXICAM 238 100 23 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 232 75 24 26
CRESTOR 223 146 25 32
METHOCARBAMOL 212 61 R 26 84
AMITRIPTYLINE HCL 211 78 R 27 48
IBUPROFEN 187 81 28 93
ACETAMINOPHEN-CODEINE 180 128 S3 29 116
DOXAZOSIN MESYLATE 178 116 30 97
FLUTICASONE PROPIONATE 176 54 31 41
KLOR-CON 10 169 79 32 90
PROAIR HFA 166 71 33 62
INSULIN SYRINGE 162 79 34 80
ZOLPIDEM TARTRATE 160 59 35 17
LEVOTHYROXINE SODIUM 156 77 36 5
ALENDRONATE SODIUM 142 126 37 44
NAPROXEN 134 68 38 100
ALLOPURINOL 132 88 39 29
FLUOXETINE HCL 132 24 39 65
GLIPIZIDE 129 67 41 74
CHLORTHALIDONE 118 57 42 142
CLONIDINE HCL 117 52 43 28
GLYBURIDE 116 50 R 44 101
NOVOLIN 70-30 115 46 45 164
DIOVAN 114 76 46 55
HYDRALAZINE HCL 114 61 46 54
CITALOPRAM HBR 111 44 48 23
LANTUS SOLOSTAR 110 60 49 121
BACLOFEN 107 36 50 153
SPIRIVA 105 42 51 72
TRAZODONE HCL 99 30 52 35
OXYBUTYNIN CHLORIDE 94 59 53 148
ATENOLOL-CHLORTHALIDONE 92 48 54 182
TRIAMTERENE-HCTZ 90 45 55 37
HUMULIN 70-30 86 39 56 106
ISOSORBIDE DINITRATE 85 53 57 218
KLOR-CON M20 80 46 58 57
POLYETHYLENE GLYCOL 3350 77 50 59 79
CLOPIDOGREL 75 56 60 34
NITROSTAT 74 30 61 244
METOPROLOL SUCCINATE 73 25 62 20
KLOR-CON M10 73 53 62 168
SULINDAC 73 19 62 268
PHENYTOIN SODIUM EXTENDED 71 27 65 128
PEN NEEDLE 69 35 66 136
ADVAIR DISKUS 69 17 66 68
VERAPAMIL ER 63 47 68 78
SINGULAIR 59 36 69 73
HYDROXYCHLOROQUINE SULFATE 58 11 70 270
TAMSULOSIN HCL 56 35 71 36
PENTOXIFYLLINE 54 35 72 266
NIFEDIPINE ER 54 34 72 115
METOCLOPRAMIDE HCL 53 12 74 102
BENAZEPRIL HCL 53 35 74 59
LANTUS 52 25 76 71
PLAVIX 52 38 76 45
PANTOPRAZOLE SODIUM 51 27 78 25
JANUVIA 50 0 79 85
CARBIDOPA-LEVODOPA 50 15 79 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.